XNAS · Healthcare · Drug Manufacturers - Specialty & Generic
Assertio Holdings Inc is a pharmaceutical company. It is engaged in comprehensive commercial capabilities, offering differentiated products designed to address patients' needs. Its focus is on supporting patients by marketing products mainly in the oncology market. The Company operates in the business within one reportable segment, relating to the sale of pharmaceutical products to its customers.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | Q1 2026 | -1.51 | -2.93 | -94.04% | $9.9M | ❌ Miss | +0.11% | +3.64% | — |
| 2026-03-16 | Q4 2025 | -2.30 | -1.06 | +53.91% | $13.5M | ✅ Beat | +4.93% | +18.95% | +53.10% |
| 2025-11-10 |
| Q3 2025 |
| -0.03 |
| 0.18 |
| +700.00% |
| $49.5M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-11 | Q2 2025 | -0.04 | 0.02 | +150.00% | $29.2M | ✅ Beat | +4.00% | +11.85% | +11.06% |
| 2025-03-12 | Q4 2024 | -0.04 | -0.03 | +25.00% | $32.2M | ✅ Beat | -7.46% | -8.82% | -20.37% |
| 2024-11-11 | Q3 2024 | -0.05 | 0.03 | +160.00% | $29.2M | ✅ Beat | -7.89% | -9.01% | +3.78% |
| 2024-08-07 | Q2 2024 | -0.03 | 0.02 | +166.67% | $31.1M | ✅ Beat | -11.79% | -13.01% | +2.44% |
| 2024-03-11 | Q4 2023 | -0.02 | 0.11 | +650.00% | $33.0M | ✅ Beat | — | — | — |
Showing last 8 quarters.